Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Joyous is a mental health company that provides low-dose ketamine therapy through a specialized telehealth platform. The company offers a subscription-based service where patients receive daily ketamine lozenges (troches) delivered to their homes, following a protocol known as Very Low Dose Ketamine (VLDK). This approach is designed to promote neuroplasticity and alleviate symptoms of depression and anxiety while minimizing the intense dissociative effects typically associated with high-dose clinical infusions. Joyous integrates a digital interface for daily patient monitoring and AI-assisted check-ins to track therapeutic progress and ensure safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Joyous Health.